KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Current Leases (2019 - 2023)

Historic Current Leases for Vir Biotechnology (VIR) over the last 4 years, with Q1 2023 value amounting to $7.3 million.

  • Vir Biotechnology's Current Leases changed N/A to $7.3 million in Q1 2023 from the same period last year, while for Mar 2023 it was $7.3 million, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2022, which is N/A changed from last year.
  • As of Q1 2023, Vir Biotechnology's Current Leases stood at $7.3 million.
  • Vir Biotechnology's 5-year Current Leases high stood at $7.3 million for Q1 2023, and its period low was $237000.0 during Q4 2019.
  • Over the past 4 years, Vir Biotechnology's median Current Leases value was $300000.0 (recorded in 2020), while the average stood at $1.8 million.
  • Over the last 5 years, Vir Biotechnology's Current Leases had its largest YoY gain of 2658.23% in 2020, and its largest YoY loss of 2658.23% in 2020.
  • Vir Biotechnology's Current Leases (Quarter) stood at $237000.0 in 2019, then rose by 26.58% to $300000.0 in 2020, then soared by 1279.0% to $4.1 million in 2022, then skyrocketed by 75.68% to $7.3 million in 2023.
  • Its Current Leases stands at $7.3 million for Q1 2023, versus $4.1 million for Q4 2022 and $300000.0 for Q4 2020.